Health · Pharma & Biotech · 22 hrs ago
Net prices of new medicines rose 35% from 2022 to 2025
A new analysis found net prices for new medicines rose sharply between 2022 and 2025.
The analysis covered 202 medicines launched in 2025 and was conducted by the Institute for Clinical and Economic Review and West Health.
Their median inflation-adjusted net price was $257,000, up from $173,000 in 2022.
Net prices account for manufacturer discounts, while list prices do not.
One in four medicines cost more than $500,000 a year, and another 34% cost between $200,000 and $500,000.
The median inflation-adjusted list price rose 24% over the same period, to $293,000, and the analysis did not explain why net and list prices changed by different amounts.
The median inflation-adjusted net price of 202 newly launched medicines rose 35% from 2022 to 2025, reaching $257,000.
About one in four medicines launched in 2025 had an annual net price above $500,000.
Another 34% of the medicines launched in 2025 had annual net prices between $200,000 and $500,000.
The analysis was conducted by the Institute for Clinical and Economic Review and West Health.
The median inflation-adjusted list price rose 24% over the same period, to $293,000.
- Who
- The Institute for Clinical and Economic Review and West Health conducted the analysis. It covered 202 newly launched medicines.
- What
- The median net price rose 35% from 2022 to 2025, reaching $257,000.
- When
- The analysis was reported on October 20, 2026, and compares prices in 2025 with those in 2022.
- Where
- Not stated
- Why
- The analysis assessed medicine prices and value. The reasons for the gap between list and net price increases were not analyzed.
This story does not have two clearly opposing sides.
The median net price of the medicines was $173,000.
The median net price reached $257,000, and about one in four newly launched medicines had an annual net price above $500,000.
STAT reported the analysis by the Institute for Clinical and Economic Review and West Health.
- Medicines studied
- 202 newly launched medicines
- Median net price
- $257,000 in 2025, up 35% from $173,000 in 2022
- Median list price
- $293,000 in 2025, up 24% from 2022
- Above $500,000
- About one in four medicines launched in 2025
- $200,000–$500,000
- 34% of medicines launched in 2025